The University of Florida Department of Urology invites you to attend
“A Novel Approach to Localized Renal Cell Carcinoma”
Aaron Brafman, MD
Department of Urology
University of Florida
Wednesday, February 3, 2016
Department of Urology Conference Room
Review the current role of systemic therapy in the treatment of renal cell carcinoma (RCC)
Understand the potential role of neoadjuvant systemic therapy (NAST) in RCC
Review the literature on NAST in relation to tumor resectability and survival for localized
Urologists, Residents, Nurses, Physician Assistants, and Staff
The University of Florida College of Medicine is accredited by the Accreditation Council for
Continuing Medical Education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Department of Urology within the University of Florida’s College of Medicine is hosting
this free event, which is internally supported.
If you have any questions please feel free to contact Chris Emery at firstname.lastname@example.org.
(Speaker) has disclosed that (he/she) has no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose
Section Number: 6124